Procept BioRobotics Corp [PRCT] stock prices are up 1.65% to $36.95 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PRCT shares have gain 6.76% over the last week, with a monthly amount glided 1.26%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on September 02, 2025, when Oppenheimer upgraded its rating to a Outperform but kept the price target unchanged to $60 for it. Previously, Stephens started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $70. On July 07, 2025, Oppenheimer initiated with a Perform rating. Morgan Stanley started tracking the stock assigning a Overweight rating and suggested a price target of $105 on December 02, 2024. Jefferies initiated its recommendation with a Hold and recommended $95 as its price target on November 14, 2024. Piper Sandler started tracking with a Overweight rating for this stock on August 11, 2023, and assigned it a price target of $42. In a note dated May 31, 2023, William Blair initiated an Outperform rating.
The stock price of Procept BioRobotics Corp [PRCT] has been fluctuating between $32.11 and $103.81 over the past year. Currently, Wall Street analysts expect the stock to reach $55 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $36.95 at the most recent close of the market. An investor can expect a potential return of 48.85% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
The Procept BioRobotics Corp [NASDAQ:PRCT] reported sales of 274.95M for trailing twelve months, representing a surge of 48.41%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at -0.33%, Pretax Profit Margin comes in at -0.31%, and Net Profit Margin reading is -0.31%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.24 and Total Capital is -0.2. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 36.04 points at the first support level, and at 35.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.57, and for the 2nd resistance point, it is at 38.19.
Ratios To Look Out For
It’s worth pointing out that Procept BioRobotics Corp [NASDAQ:PRCT]’s Current Ratio is 9.20. In addition, the Quick Ratio stands at 7.86 and the Cash Ratio stands at 6.09. Considering the valuation of this stock, the price to sales ratio is 7.48, the price to book ratio is 5.32.
Transactions by insiders
Recent insider trading involved MOLL FREDERIC H, Director, that happened on Aug 13 ’25 when 20000.0 shares were purchased. Director, Desai Antal Rohit completed a deal on Jun 10 ’25 to sell 25000.0 shares. Meanwhile, Director Desai Antal Rohit sold 25000.0 shares on Jun 11 ’25.
